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PENILAIAN PENGAMBILAN ORAL JANGKA PANJANG MADU TUALANG 
DIIRIDIASI GAMMA DALAM TIKUS ‘SPRAGUE-DAWLEY’ BEBAS 
PATOGEN KHUSUS 
 
ABSTRAK 
 
Madu Tualang diiridiasi gamma (GITH) dilaporkan mempunyai aktiviti 
antioksidan, keupayaan menggarut radikal bebas yang tinggi, aktiviti anti kanser, anti-
bakteria, anti-radang dan juga penyembuhan luka. Oleh yang demikian, kajian terperinci 
bagi menilai kesan pengambilan oral jangka panjang diperlukan. Kajian dilaksanakan 
menurut Garis Panduan „The Organisation for Economic Cooperation and 
Development’ (OECD) no. 452, dengan sedikit pengubahsuaian. Tikus „Sprague- 
Dawley’ bebas patogen khusus (SPF) berjumlah 120 ekor (berumur 6 ± 1 minggu) jantan 
dan betina dibahagi secara rawak kepada empat kumpulan (n = 10-20 setiap satu) dan 
GITH diberi secara oral  pada dos [0 (Kumpulan I), 0.2 (Kumpulan II), 1.0 (Kumpulan 
III) dan 2.0 g / kg berat badan (Kumpulan IV)] setiap hari selama enam bulan. Kadar 
mortaliti, morbiditi, penilaian fizikal, tingkah, berat badan direkod. Selepas enam bulan, 
sampel darah tikus yang dipuasakan semalaman dikumpulkan untuk pemeriksaan 
parameter hematologi  dan biokimia klinikal. Bedahsiasat penuh dijalankan. Berat organ 
mutlak (AOW)  dan relatif (ROW) telah diukur. Kajian histologi ke atas kelenjar 
adrenal, ginjal dan hepar dijalankan. Tiada mortaliti, morbiditi,  perubahan signifikan  
pada rekod berat badan diantara semua kumpulan dicerap. Kumpulan II (jantan dan 
betina) menunjukkan peningkatan dalam ‘mean corpuscular haemoglobin 
concentrations’ (MCHC) berbanding Kumpulan IV (jantan) dan semua kumpulan lain 
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(betina). Nilai „mean corpuscular haemoglobin’ (MCH) yang tinggi diperhatikan bagi 
tikus betina (Kumpulan II) berbanding kumpulan lain. Kumpulan IV (jantan) 
mempunyai nilai ‘blood urea nitrogen’ (BUN) yang rendah berbanding Kumpulan I dan 
II. Nilai rendah yang signifikan bagi „alanine transaminase’ diperhatikan pada semua 
kumpulan GITH (jantan) berbanding Kumpulan I. Tiada perubahan ketara pada organ 
dalaman tikus dan tiada perbezaan AOW dan ROW. Penilaian histologi menunjukkan 
morfologi normal pada kelenjar adrenal, ginjal dan hepar untuk semua kumpulan tikus. 
Analisis histomorfometri kelenjar adrenal menunjukkan kelebaran kawasan zona 
fasciculata yang menurun  pada semua kumpulan penerima rawatan GITH (jantan) dan 
Kumpulan II (betina) berbanding Kumpulan I. Pembesaran kawasan „Bowman’s space’ 
diperhatikan pada Kumpulan IV (jantan) berbanding Kumpulan I dan III. Perbezaan 
signifikan pada saiz sel hepar dwinukleus dalam Kumpulan II dan III berbanding 
Kumpulan I (jantan); dan Kumpuan IV berbanding Kumpulan II dan III (betina) 
diperhatikan. Kesimpulannya, pengambilan oral jangka panjang GITH pada tikus SPF 
tidak memberi kesan negatif dalam parameter yang dikaji. Secara keseluruhan, kajian 
menunjukkan GITH memelihara fungsi normal kelenjar adrenal, ginjal dan hepar tikus 
dan mungkin ada kesan positif yang memerlukan kajian lanjut. 
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EVALUATION OF LONG TERM ORAL ADMINISTRATION OF GAMMA 
IRRADIATED TUALANG HONEY IN SPECIFIC PATHOGEN FREE 
SPRAGUE-DAWLEY RATS 
 
ABSTRACT 
 
Gamma irradiated Tualang honey (GITH) is reported to have high antioxidant 
and free radical scavenging activities along with its anticancer, antibacterial, anti-
inflammatory and wound healing properties. A detailed study to evaluate its long term 
oral administration is therefore, necessary. The study design was adapted from The 
Organisation for Economic Cooperation and Development (OECD) Guideline no. 452 
with slight modifications. A total of 120 healthy male and female specific pathogen free 
(SPF) Sprague-Dawley rats (6±1 weeks old) were randomly divided into four groups 
(n=10-20 each) fed with different GITH doses [0 (Group I), 0.2 (Group II), 1.0 (Group 
III) and 2.0 g/kg body weight] (Group IV) daily for six months. Weekly body weight, 
mortality and morbidity, physical appearance and behavioural characteristics were 
recorded. After six months, blood sample of overnight fasted rats were analysed for 
haematology and clinical biochemistry parameters. Full gross necropsies were 
conducted followed by the determination of absolute and relative organ weights (ROW) 
were determined. Adrenal glands, kidneys and liver were then subjected to histological 
assessments. The study revealed that no morbidity and mortality were observed and no 
significant changes in body weight recorded between all groups. Group II (male and 
female) possessed significantly higher mean corpuscular haemoglobin concentrations 
(MCHC) when compared to Group IV (male) and other groups (female). Higher mean 
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corpuscular haemoglobin (MCH) values were observed in female rats (Group II) when 
compared with other groups. Group IV (male) have lower blood urea nitrogen (BUN) 
when compared to Group I and II. Significantly lower alanine transaminase were 
observed in all GITH treated groups (male) in comparison with control group. No 
noticeable changes in gross appearance of rats internal organs were seen with no marked 
changes in absolute and ROW.  Histological examinations revealed normal morphology 
of adrenal glands, kidneys and livers for all the rats. Histomorphometry analysis of 
adrenal glands revealed lower width of zona fasciculata regions in all GITH treated 
groups (male) and Group III (female) when compared to Group I. Dilatation of 
Bowman‟s space were observed in Group IV (male) in comparison to Group I and III. 
Significant variations of binucleated hepatocytes size in Group II and III as compared to 
Group I (male); and Group IV when compared to Group II and III (female) was 
observed. In conclusion, long term oral administration of GITH does not produce any 
detrimental effects in the body weight, physical and behavioural characteristics, as well 
as clinical laboratory analysis and histopathological parameters. Hence, overall findings 
suggested that GITH preserved the normal functions of adrenal glands, kidney and liver 
of SPF rats and may contribute to positive effects that warrant further evaluations. 
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CHAPTER ONE 
 
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Complementary medicines, Apitherapy and natural medicines 
Complementary and alternative medicines (CAM) are defined as a group of 
diverse medical and health care organizations that are not considered as a part of modern 
conventional medicine. Complementary medicines are usually practiced along with 
conventional methods. While, Integrative medicine combines mainstream medical 
therapies and CAM based on its scientific evidence of the safety and effectiveness 
(NCCIH, 2008). Normally in some countries, the terms complementary or alternative 
medicines are utilized interchangeably with traditional medicines (WHO, 2000). 
An alternative medicinal branch called Apitherapy has been developed  recently 
utilizing honey and other bee products such as bee venom, propolis and royal jelly in the 
treatments of many illnesses (Bogdanov et al., 2008; Bogdanov, 2010). Some of the 
ailments treated are multiple sclerosis, shingles, gout, burns and wounds, tendonitis, 
pain, and infections.  
The National Centre for Complementary and Integrative Health (NCCIH) (2008) 
estimated that approximately 40% Americans resorts to alternative medicine for their 
general well being. Moreover, in a 2007 interview surveys done by the National Institute 
of Health (NIH) concluded that approximately 17.7% adults in America had used natural 
products in the past such as fish oil or omega- 3.  
On the other hand, based on the survey conducted by Malaysian Ministry of 
Health (MOH) in 2004, approximately 69% of Malaysians have utilized traditional and 
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complementary medicine in their lifetime and 88.9% among them use a biologically-
based therapy such as herbal medicines or vitamins supplements either for their general 
health and boosting immune system, improving quality of life or combat symptoms of 
illnesses  (Dhanoa et al., 2014; Globinmed, 2015). Additionally, Aziz and Tey (2008) 
reviewed that the estimated annual sales of traditional medicine in Malaysia have 
increased from RM 1billion to RM 4.5 billion within the duration of five years ( 2000 to 
2005). 
Moreover interview-based studies done by a team of researchers showed high 
prevalence in CAM utilization amongst general populations and cancer patients as well 
(Aziz and Tey, 2008; Siti et al., 2009; Dhanoa et al., 2014). Mostly their choice of 
treatment alongside with conventional modern medicine is by consumptions of 
traditional herbs and vitamins and mind-body techniques such as prayers, yoga and 
meditations (Siti et al., 2009; Dhanoa et al., 2014). 
In line with the marketing upsurge and easily available dietary supplements such 
as herbs, vitamins and minerals, it raised a special concern on the occurrence of adverse 
effects which are likely to arise from overdoses or herbal-drugs interaction that can put 
an additional risk to the consumer. Consequently, the need to learn about the effects of 
these products to the human body and their safety profile becomes of great importance. 
 
1.2 Honey 
Honey is a complex substance which composed mainly of water, different types 
of carbohydrates, proteins, small quantities of vitamins, minerals and trace elements 
along with aromatic compounds and polyphenols. Nevertheless, the exact contents and 
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composition of honey are in accordance to its floral origin, plant species as well as 
geographical and climates in which the honeybees forages.  
This sweet, viscous substance is made by means of several processes of 
regurgitation by bees. The flower nectars (mono/multi-floral) comprise almost 80% of 
water and complex sugars, were carried by bees through their honey stomach back to the 
hive and passed to other worker bees where it will undergo the chewing process and 
converted into simple sugars. Evaporation of excess water from the nectars was allowed 
in the honeycombs. The bees will then chew the nectars once more after the nectar is 
thicken and honey is produced (Al-Waili, 2003b). 
Well known to be flavourful with high nutritional and therapeutic values.  It has 
been widely marketed as a natural sweetener and dietary supplements. As some called it 
a „functional food‟ (Bogdanov, 2010) that is capable of  exhibiting positive health effects 
(Nantel, 1999). 
 
1.2.1 Honey and its nutritional components 
 
1.2.1.1 Carbohydrates 
Ninety-five percent of honey dry weight comprises of carbohydrates 
predominantly fructose (38.5%) and glucose (31.0%). Additionally, about 25 different 
sugars were detected with oligosaccharides (sucrose, maltose, turanose, erlose, 
melezitose and raffinose) while trace amounts of tetra and pentasaccharides have been 
identified. Generally, honeys with high fructose are sweeter compared with the ones 
with high glucose content (Bogdanov et al., 2008; Bogdanov, 2009a; Bogdanov, 2009b). 
Since fructose and glucose were readily transported in the blood stream, honey can be an 
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excellent source of instant energy. Twenty grams of honey taken orally will cover about 
three percent of human required daily energy (Bogdanov et al., 2008; Bogdanov, 
2009b). Oligosaccharides is a product of honey enzyme invertase activities which can 
serve as prebiotic agent (White, 1975; Chow, 2002; Bogdanov, 2009a). 
 
1.2.1.2 Proteins 
Proteins, primarily enzymes and amino acids made up about 0.5%-0.7% of honey 
contents. Virtually all physiologically important amino acids were present in honey. 
However, since the amount is relatively small, it has very little nutritive effects to the 
human body (Bogdanov et al., 2008; Bogdanov, 2009b; Bogdanov, 2009a) 
Besides amino acids, several enzymes were present in honey. These enzymes 
namely were diastase, invertase, glucose oxidase, catalase, acid phosphatase, protease, 
esterase and β-glucosidase (Bogdanov et al., 2008; Bogdanov, 2009b; Bogdanov, 2009a) 
and were responsible in honey functional properties which make it a unique sweetener. 
Major enzymes in honey are diastase (amylase) which is capable of converting 
polysaccharides (starch) or oligosaccharides (glycogen) to simpler sugar by breaking the 
glycosidic bonds. Next is invertase which catalyses conversion of sucrose to fructose and 
glucose and glucose oxidase which are responsible for conversion of glucose to gluconic 
acid and hydrogen peroxide (contributes to antibacterial properties of honey) (Bogdanov 
et al., 2008; Bogdanov, 2009a; Bogdanov, 2009b; Kowalski et al., 2012). 
Glucose oxidase is generally inactive in honey which is merely activated by 
dilution of pure honey (Al-Mamary et al., 2002). In earlier years, invertase and diastase 
were used to evaluate honey freshness upon storage or heating (Bogdanov et al., 2008; 
Bogdanov, 2009a) 
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1.2.1.3 Vitamins, mineral and trace elements 
Fairly small amounts of vitamins, minerals and trace elements were found in 
honey (Table 1.1) which has very little influence in accordance with the recommended 
daily intake for humans. The different values were mainly due to the botanical origin of 
honeys (Bogdanov et al., 2008; Bogdanov, 2009a; Bogdanov, 2009b) 
 
1.2.1.4 Aromatic and volatile compounds of honey 
Volatile compounds which originate mostly from botanical origin of honey are 
responsible for its tastes and aroma. Widespread research on honey aromatic compounds 
had identified about 600 compounds (Bogdanov, 2009a).  One of it is polyphenols 
groups, mainly flavonoids for example quercetin, luteolin, kaempferol, apigenin, 
galangin, phenolic acids and phenolic acid derivatives (Bogdanov, 2009b), which are 
plant-derived secondary metabolites. These compounds are mainly accountable for the 
honey anti-oxidative capacity. Darker coloured honeys reportedly have more  phenolic 
acid derivatives but lesser flavonoids (Bogdanov, 2009a). It was proven by several 
studies that darker coloured honey has more antioxidant content than honey with lighter 
colour (Taormina et al., 2001; Gheldof et al., 2002; Schramm et al., 2003; Kinoo et al., 
2012). 
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Table 1.1 Honey vitamins and minerals values as well as trace elements adapted from Bogdanov et al, (2008) and Bogdanov, (2009b) 
 
Vitamins  
(mg) 
Amount in 
100g 
Minerals  
(mg) 
Amount in 
100g 
Element mg/100 g Element mg/100 g 
Phyllochinon (K) Ca. 0.025 Sodium (Na) 1.6-1.7 Aluminium (Al) 0.01-2.4 Lead (Pb) * 
0.001-
0.03 
Thiamin (B1) 0.00-0.001 Calcium (Ca) 3- 3.31 Arsenic (As) 
0.014-
0.026 
Lithium (Li) 
0.225-
1.56 
Riboflavin (B2) 0.01-0.02 Potassium (K) 40-3500 Barium (Ba) 0.01-0.08 
Molybdenum 
(Mo) 
0-0.004 
Pyridoxine (B6) 0.01-0.32 
Magnesium 
(Mg) 
0.7-1.3 Boron (B) 0.05-0.3 Nickel (Ni) 0-0.051 
Niacin 0.1-0.2 Phosphorus (P) 2-15 Bromine (Br) 0.4-1.3 Rubidium (Rb) 0.040-3.5 
Panthothenic acid 0.02-0.11 Zinc (Zn) 0.05-2 
Cadmium (Cd) 
* 
0-0.001 Silicon (Si) 0.05-24 
Ascorbic Acid 
(C) 
2.2-2.5 Copper (Cu) 0.02-0.6 Chlorine (Cl) 0.4-56 Strontium (Sr) 0.04-0.35 
  Iron (Fe) 0.03-4 Cobalt (Co) 0.1-0.35 Sulphur (S) 0.7-26 
  
Manganese 
(Mn) 
0.02-2 Floride (F) 0.4-1.34 Vanadium (V) 0-0.013 
  Chromium (Cr) 0.01-0.3 Iodide (I) 10-100 Zirconium 0.05-0.08 
  Selenium (Se) 0.002-0.01     
 
(*) Toxic elements 
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1.3 Tualang honey 
Tualang honey is named after one of the tallest trees (>85m) in Malaysia, 
Tualang tree (Koompasia excelsa), which is indigenous, mostly to peninsular Malaysia, 
southern Thailand, Borneo and Palawan region. It is produced  by  Asian rock bees (Apis 
dorsata) deemed to be the world‟s largest and most ferocious bees (mySinchew, 2011; 
Shah et al., 2013). 
 
1.3.1 Physicochemical characteristics and nutritional values of Tualang honey 
Due to its multifloral botanical origin, it has dark brown (Tumin et al., 2005) to 
amber (Moniruzzaman et al., 2013a) in appearance. Because of its tropical origin, 
Tualang honey has somewhat higher water content (23.6%) compared to honeys 
originating from temperate regions (Jeffrey and Echazarreta, 1996). This high moisture 
content can be reduced by the process of evaporation to decrease the probability of 
honey spoilage by fermentation. It is acidic with an average pH value of 3.4 and total 
acid content of 35.12 meq/kg. The other criteria such as specific gravity, HMF value, 
soluble solid were within the limit set up by international regulations (Codex 
Alimentarious Commission, 2000). Table 1.2 summarized the physicochemical 
properties of Tualang honey as described by extensive research carried out by previous 
researchers.  
Trace elements (Table 1.3)  that are commonly found in different types of  
honeys were present in Tualang honeys with sodium (Na), potassium (K), iron (Fe) and 
calcium (Ca) being the most abundant (Chua et al., 2012; Moniruzzaman et al., 2014). 
The level of trace elements found in honey is within permissible limits set by a joint 
committee of FAO/WHO (2007). 
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Over 35 volatile compounds has been identified in Tualang honey which consist 
of 59% of hydrocarbons, 11% ketones, 10% aldehydes, 8% furans, 7% acid/alcohol, 1% 
organic acids (Shah et al., 2013). 
Tualang honey possessed relatively high antioxidants contents mainly phenolics 
and flavonoids compounds (Table 1.4) which in turn gives high antioxidant capacities 
(Mohamed et al., 2010; Khalil et al., 2011a; Khalil et al., 2011b; Kishore et al., 2011; 
Khalil et al., 2012; Chua et al., 2013; Moniruzzaman et al., 2013a). 
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Table 1.2 Physicochemical properties and nutritional profile of Tualang honey 
 
Parameters Amount Parameters Amount 
Colour appearance 
Dark brown to 
amber 
Glycaemic Index 
Intermediate 
65 
Intensity (ABS450) 489.5-544.33 Total CHO (%) 72.94 
Moisture content (%) 22.32-26.51 
Total Sugar content (g/100g 
honey) 
63.60 
pH 3.2-3.8 Reducing sugar (g/100g honey) 61.94-67.50 
Specific gravity 1.335 
Apparent sucrose (g/100g 
honey) 
0.60- 1.66 
Water insoluble solid 
(%) 
0.8 Fructose/glucose ratio (%) 0.885 
Ash 0.19-0.2 Sucrose/ maltose ratio (%) 0.226 
Electrical conductivity 0.5-1.37 Glucose/water (%) 1.574 
Diastase activity 
(Number) 
2.0 Fructose (%) 29.60 -41.732 
HMF (mg/kg) 1.7 Glucose (%) 30- 47.13 
Free acid (Meq/kg) 32.9 – 37.33 Maltose 4.49 -7.90 
  Total Lipid content (mg/100g) 100 
  Protein (%) 0.36- 0.483 
  Proline (mg/kg) 248.53 
  Thiamine (B1) <LOQ 
  Riboflavin (B2) <LOD 
  Nicotinic acid (B3) 170.38 
  Folic acid (B9) <LOQ 
  Cyanocobalamin (B12) <LOD 
  Ascorbic acid (C) 52.20 
 
LOQ: Limit of Quantification; LOD: Limit of Detection 
 
Range of values in the Table 1.2  is as described in various studies by different 
researchers all over Malaysia  (Tumin et al., 2005; Robert and Ismail, 2009; Khalil et al., 
2010; Mohamed et al., 2010; Zakaria et al., 2011; Jaafar et al., 2012; Ahmed and 
Othman, 2013; Chua et al., 2013; Moniruzzaman et al., 2013a; Chua and Adnan, 2014). 
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Table 1.3 Minerals and trace elements identified in Tualang honey 
 
Elements 
Amount (ppm) as 
determine by Chua 
et al  (2012) 
Amount (mg/kg) as 
determined by 
Moniruzzaman (2014) 
Amount (%) as 
summarized by Ahmed 
and Othman (2013) 
Aluminium 
(Al) 
1.120 - - 
Arsenic (As) nd 0.062 - 
Barium (Ba) nd - - 
Boron (B) - - - 
Bromine (Br) - - - 
Cadmium 
(Cd)* 
nd nd - 
Calcium - 165.10 0.18 
Chlorine (Cl) - - - 
Chromium 
(Cr) 
1.845 - - 
Cobalt (Co) nd 0.033 - 
Copper (Cu) 0.093 1.25 - 
Fluoride (F) - - - 
Indium (In)* 0.226 - - 
Iodide (I) - - - 
Iron (Fe) 11.097 128.13 - 
Lead (Pb)* nd 0.183 - 
Lithium (Li) nd - - 
Magnesium 5.209 35.03 0.11 
Manganese 1.992 - - 
Molybdenum 
(Mo) 
- - - 
Nickel (Ni) nd - - 
Potassium 1199.65 1576.40 0.51 
Rubidium 
(Rb) 
5.188 - - 
Selenium 17.202 - - 
Silicon (Si) - - - 
Sodium (Na) 370 268.23 0.26 
Uranium* 0.040 - - 
Strontium 
(Sr)* 
0.113 - - 
Sulfur (S) - - - 
Vanadium (V) nd - - 
Zinc 3.316 13.20 - 
Zirconium - - - 
 
(*) Toxic elements that could be due to man-made origin, (nd) non detected, (-) not 
considered in the particular study  
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Table 1.4 Antioxidant activities and antioxidant compounds found in Tualang honey 
 
Parameters Values 
Total phenolics 
(mg/GAE/100g honey) 
83.96-110.39 
Total flavonoids 
(mg catechin/kg) 
50.45 
FRAP values 
(mg TE/100g honey) 
52.39 
DPPH 
(% inhibition) 
9.65 
Phenolic Acids 
p-coumaric acid 
Caffeic acid 
Ferulic acid 
Trans-cinnamic acid 
Chlorogenic acid 
Gallic acid 
Syringic acid 
Benzoic acid 
Flavonoids 
Pinobanksin-3-O-butyrate 
Quercetin 
Catechin 
Naringenin 
Kaempferol 
Organic acids 
Fumaric acid 
Gluconic acid 
 
As determined by Mohamed et al., (2010); Khalil et al., (2011a; 2011b); Kishore et al., 
(2011) Chua et al., (2013) and Moniruzzaman et al., (2013a).  
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1.4 Contaminants in honey 
Like any other food source, honey could be exposed to different kinds of 
contaminants (microorganisms, heavy metal, pesticide, antibiotic and other toxic 
materials) from the environment either by bees or in the processing and packaging of the 
honey (Bogdanov, 2006; Bogdanov, 2008; Bogdanov, 2009a; Bogdanov, 2009b). 
 
1.4.1 Heavy metals, pesticides and antibiotics 
There have been incidences in contamination of honey with heavy metals such as 
arsenic (As), lead (Pb) and cadmium (Cd), radioactive materials (Bogdanov, 2006; Chua 
et al., 2012; Islam et al., 2013) as well as organic contaminants such as polychlorinated 
biphenyls. These contaminants are mainly introduced into the honey through the 
environment, for instance from soil and man-made products which include motor oil, 
during packaging as well as indirectly through the honeybees (Bogdanov, 2006; Islam et 
al., 2013). 
The residual amount of pesticides that were used in agricultural industries had 
been detected in European honeys (Bogdanov, 2006), moreover there have been growing 
concern over the contaminations by antibiotics that was used against bee brood diseases 
(Bogdanov, 2006; Bogdanov et al., 2008; Bogdanov, 2009a). 
 
1.4.2 Microorganisms 
Due to its high osmotic pressure, acidity and low pH value as well as hydrogen 
peroxide content, the microorganism found in honeys is very limited since the condition 
is not favourable for microorganism growth (Al-Mamary et al., 2002; Bogdanov, 2010). 
However, studies have reported finding colonies of osmotolerant yeasts, moulds, 
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Bacillus species as well as Clostridium botulinum spores (Snowdon and Cliver, 1996; 
Iurlina and Fritz, 2005).  
Most honeys contain small amounts of yeasts and moulds  (Snowdon and Cliver, 
1996; Iurlina and Fritz, 2005). In a study done by Iurlina and colleague (2005), they 
found out that yeasts and were found in 57% out of 70 unpasteurized Argentineans 
honeys.  These yeasts that were present in honeys can cause unwanted fermentation and 
it was made possible by honey with high moisture content. A moisture content above 
20% raised the chances of yeast fermentation in honeys (Bogdanov, 2009a).  
Paenibacilus larvae (spore forming bacteria),  major pathogens for honey bees 
were also identified alongside Bacillus sp such as B. cereus, B. pumilus and B. 
Laterosporus spores (Snowdon and Cliver, 1996; Iurlina and Fritz, 2005). 
Usually, the primary source of microbial contaminations is likely introduced by 
pollen, digestive tract of honey bees, dusty air, earth and nectar. Secondary sources of 
contamination were due to post harvesting of the honeys such as packaging, food 
handlers, cross-contamination, equipment and building (Bogdanov, 2006). 
 
1.4.3 Hydoroxymethylfurfuraldehyde (HMF) 
HMF normally presents in trace amounts in fresh honeys which are a product of 
fructose decomposition. Concentration of HMF is normally increased, with  storage and 
prolonged heating (Bogdanov, 2009a). Codex Alimentarious Commissions and 
European Union (EU) (2000) have standardized the limit of HMF content in honey to be 
not exceeding 40mg/kg and for honey originating from tropical countries to be not 
exceeding 80mg/kg. 
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1.5 Remedial use of honey 
Copious health benefits of honey made it an important aspect of complementary 
and traditional medicines especially in Apitherapy. Growing interest has been based on 
multi faceted medicinal properties of honey namely antibacterial; wound healing, 
antioxidant, anticancer and anti-inflammatory activities. Honey has gained great work 
momentum by researchers both in vitro and in vivo round the globe to spark the 
unknown benefit of the infinite attributes as well as its applications to modern medicine.  
 
1.5.1 Antimicrobial activity 
The most studied medicinal attributes of honey were its anti-microbial activities. 
Generally honey possess highly effective broad spectrum antibacterial activities against 
infections caused by both gram positive and gram negative bacteria (Molan and Allen, 
1996; Taormina et al., 2001; Aljadi and Yusoff, 2003; Lusby et al., 2005; Estevinho et 
al., 2008; Tan et al., 2009; Khoo et al., 2010; Nasir et al., 2010; Saxena et al., 2010; 
Kirnpal-Kaur et al., 2011; Kinoo et al., 2012; Zainol et al., 2013) 
Besides its natural physical attributes such as high osmolarity, low pH value and 
low water content that are unfavourable for bacterial growth, hydrogen peroxide 
activation is primarily the contributing factors in bacteriostatic and bactericidal effects of 
honey. Some phytochemicals compounds (Al-Mamary et al., 2002; Kinoo et al., 2012) 
that are present in honey also contribute to its antibacterial effects. Even though the 
chemical constituents of honey might be a little different from one another, they all still 
exhibit good antimicrobial activities. Table 1.5 summarizes the antibacterial properties 
of Tualang honey against gram positive and gram negative bacteria.  
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Table 1.5 List of bacteria that are known to be sensitive to Tualang honey 
 
Gram positive bacteria Gram negative bacteria 
Streptococcus pyogenes Escherichia coli 
Coagulase-negative Staphylococci Salmonella  enterica serovar typhi 
Staphylococcus aureus Stenotrophomonas maltophilia 
Methicillin- resistant Staphylococcus aureus Acinetobacter baumanii 
Streptococcus agalacticae Pseudomonas aeruginosa 
Bacillus cereus Proteus mirabilis 
 Shigella flexneri 
 Enterobacter cloacae 
 
(Tumin et al., 2005; Tan et al., 2009; Kirnpal-Kaur et al., 2011; Ahmed and Othman, 
2013; Zainol et al., 2013) 
 
1.5.2 Wound healing 
It was revealed that honey can support wound healing either burn and infected 
wounds or ulcers by accelerating the re-epithelisation and promoting granulation and 
tissue formation (Nawfar et al., 2011), eliminating bacterial infections (Nasir et al., 
2010; Sukur et al., 2011) and providing moist environment and nutrient essential for 
wound healing.  
Different therapeutics properties of honey exhibits synergistic effect in 
combination with conventional antibiotics or wound dressing biomaterial such as 
hydrogel and hydrofiber
®
 and showed comparable results when compared with 
commercial dressing materials such as silver hydrogel and so on (Imran et al., 2011; 
Rodzaian et al., 2011; Lazim et al., 2013).  
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1.5.3 Source of antioxidants and protective effects of honey against oxidative 
stress 
Antioxidants compounds are nutritive and non-nutritive agents that can impede 
biologically detrimental chemical reaction of free radicals and reactive oxygen species 
(ROS). Free radicals and ROS compounds are responsible in increasing oxidative 
damage in many molecules for examples lipids, proteins and nucleic acids (Erguder et 
al., 2008) which contributes to cellular dysfunction and accountable for pathogenesis of 
diseases, such as cancer, cardiovascular diseases and neurodegenerative diseases  
(Busserolles et al., 2002; Gheldof et al., 2003; Schramm et al., 2003). 
Separate studies done by different researchers have reported that consumption of 
honey can increase serum antioxidant capacity, plasma antioxidant content and 
consequently will increase the protectiveness of human body against damaging effects of 
free radicals species (Al-Waili, 2003a; Gheldof et al., 2003; Schramm et al., 2003). 
Number of studies performed by different researchers concluded that Tualang 
honey has high antioxidant content which has significant correlation between high total 
phenolic content and free radical scavenging activities of honey (Hussein et al., 2011; 
Kishore et al., 2011; A-Rahaman et al., 2013). This is  also substantiated via in vitro 
studies that showed protective effects in cellular resistance to oxidative stress (Tan et al., 
2014) and Ultraviolet B (UVB) radiation (Ahmad et al., 2012).  
 
1.5.4 Anti-proliferative, anti-cancer and anti-inflammatory effects of honey 
Tualang honey has been shown to exhibit anti-proliferative and apoptotic  effects  
in human keloid fibroblast (Syazana et al., 2011), oral squamous and osteosarcoma cell 
lines (Ghashm et al., 2010),  as well as human breast and cervical cell lines  without 
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harming normal healthy cells (Fauzi et al., 2011). Similar study done using Greek honey 
extracts revealed a significant effect on human cancer cells mainly breast, endometrial 
and prostate (Tsiapara et al., 2009) owing to its phenolic contents. Additionally, in vivo 
study conducted by Kadir et al  (2013) showed that long term oral ingestion of Tualang 
honey can reduce aggressiveness of DMBA-induced breast cancer development in 
female rats. It is also observed in this study that with increasing doses of Tualang honey 
(0.2, 1.0 and 2.0g/kg); there was an increasing trend of apoptotic index (AI) of the 
cancer cells.  
Adequate inflammatory response is needed in order to eliminate harmful irritants 
whether it is a microbial or non-microbial origin. However, excessive inflammatory 
responses can be detrimental to human health. Honey exhibits potent anti-inflammatory 
responses. Othman (2012) reviewed that topical application of a mixture containing 
honey, olive oil and beeswax can reduce the occurrence of diaper dermatitis in infants 
and topical application of honey can improve dermatitis and Psoriasis vulgaris 
pathogenesis. Furthermore, it is proven that oral supplementation of Tualang honey 
reduces inflammatory response of upper respiratory tracts (Sulaiman et al., 2011; 
Asha'ari et al., 2013) among affected individuals. Similarly, inhalation of Tualang honey 
reduces inflammatory cells response and airway inflammation in rabbits (Kamaruzaman 
et al., 2014). 
 
1.5.5 Protective effects of honey against metabolic diseases 
Several animal studies and clinical trials had concluded that honey intake either 
short term or long term can ameliorates the risk factors for metabolic and cardiovascular 
diseases in animal models or in individuals at risk and patients of cardiovascular diseases 
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(Busserolles et al., 2002; Chepulis, 2007a; Chepulis and Starkey, 2008; Fasanmade and 
Alabi, 2008; Yaghoobi et al., 2008; Najafi et al., 2011).  
Earlier researchers further established that honey intake had metabolic and 
cardiovascular significance by evaluating the routine health profiles. There were 
reductions in  indices that are known as risk factors for cardiovascular disease such as 
total cholesterol, triglycerides, low density lipoprotein (LDL)  and C-reactive protein  
with the increment of high-density lipoprotein (HDL) level, higher  plasma vitamin E 
and C (Busserolles et al., 2002; Al-Waili, 2003a; Chepulis and Starkey, 2008; Yaghoobi 
et al., 2008; Alagwu et al., 2009; Mundstedt et al., 2009; Alagwu et al., 2011; Nemoseck 
et al., 2011; Nasrolahi et al., 2012; Majid et al., 2013). 
Honey has been proven to decrease blood glucose (Erejuwa et al., 2011a; Nazir 
et al., 2014), glycated haemoglobin (HbA1c) level (Chepulis, 2007a) and increase blood 
insulin level (Erejuwa et al., 2011a) in both healthy and diabetic patients as well as 
animal models. Moreover in separate studies it is revealed that honey consumption by 
patients with type I (Abdulrhman et al., 2013) and type II (Nazir et al., 2014) diabetes 
mellitus (DM) had lower glycaemic response in comparison with glucose consumption. 
These indicate that honey is suitable as a sugar alternative in diabetic management and 
prevention.  
 
1.5.6 Kidney functions 
Reduced level of blood urea nitrogen (BUN) (Al-Waili, 2003c; Al-Waili et al., 
2006b; Abdel-Moneim and Ghafeer, 2007), creatinine (Al-Waili, 2003c; Abdel-Moneim 
and Ghafeer, 2007; Erejuwa et al., 2011a) were observed in honey fed rats either healthy 
or diseased.  
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1.5.7 Hepatoprotective effects 
Both clinical trial and in vivo studies showed that when honey was supplied via 
inhalation (Al-Waili, 2003c; Mostafa et al., 2012) or oral consumption (Al-Waili et al., 
2006a; Al-Waili et al., 2006b), it can exhibit hepatoprotective attributes. Reduction of 
liver enzyme activity such as aspartate aminotransferase (AST) ,alanine transaminase 
(ALT)  and alkaline phosphatase (ALP) (Erejuwa et al., 2012) was observed after 
repeated inhalation or oral consumption of honey (Al-Waili, 2003c; Al-Waili et al., 
2006a; Al-Waili et al., 2006b; Abdel-Moneim and Ghafeer, 2007; Erejuwa et al., 2012; 
Mostafa et al., 2012). Significant decrease of total bilirubin was also seen after repeated 
exposures to honey (Mostafa et al., 2012). 
 
1.5.8 Haematology and immunity 
Honey has been found to be beneficial to reduce anaemic incidence in 
individuals and enhance the immunity parameters. Chepulis (2007b) documented that 
dietary intake of honey in young rats increases the percentages of neutrophil and 
lymphocytes. This aligned with earlier studies by Al-Waili (2003c) that disclosed honey 
intravenous infusion elevates the level of haemoglobin, white blood cells and eosinophil 
percentage in healthy sheep. Same researcher also examined the effects of honey 
ingestion after acute blood loss in animal models. This study revealed that there is an 
increment in the level of haemoglobin before and after acute haemorrhage (Al-Waili et 
al., 2006b). Nutritional constituents in honey such as minerals and trace elements might 
serve to stimulate haemoglobin synthesis. In separate clinical trial, Al-Waili (2006a) also 
documented an enhanced immunological indices such as lymphocytes percentage, 
platelet count in AIDS patient given 3 weeks of supplementation of honey. 
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1.5.9 Reproductive and developmental 
Honey (Tualang honey) has been shown to have hormonal regulations effects 
either in male or females subjects.  Daily oral supplementation of Tualang honey for two 
weeks prevents uterine atrophy and excessive weight gain as well as, increased bone 
mass in ovariectomised rats (Zaid et al., 2010). Two other studies showed that Tualang 
honey enhances the memory of postmenopausal women compared to women receiving 
hormone replacement treatment (HRT) therapy (Othman et al., 2011; Shafin et al., 
2014). Consequently Tualang honey can be suggested as an alternative to HRT therapy 
in postmenopausal women. In a different study, daily supplementation of Tualang honey 
for four weeks at the dose of 1.2g/kg significantly enhanced spermiogenesis in rats by 
increasing epididymal sperm count (Mohamed et al., 2011).  
 
1.6 Review on other Malaysian honey 
There are several types of local Malaysian honey  (Table 1.6) that has been 
studied apart from Tualang honey which includes Malaysian Gelam honey, Acacia 
honey, Nenas honey and recently Borneo honey namely for their physicochemical and 
antioxidant properties (Aljadi and Kamaruddin, 2004; Khalil et al., 2011b; 
Moniruzzaman et al., 2013a). These honeys are called tropical honey since it is 
originated from tropical countries (Khalil et al., 2011b)  and were collected from several 
states across Malaysia. 
Among these types of honeys, Tualang and Gelam honey were the most widely 
studied followed by Acacia due to their therapeutic properties and availabilities (Khalil 
et al., 2011b). However recently, Trigona honey has gained recognition amongst local 
population. 
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Gelam honey is a wild honey produced by two species of bees which are Apis 
dorsata and Apis mellifera. Normally the bees‟ colonies collect nectar from the same 
floral source which is Gelam tree (Melaleuca cajuputi powell) (Khalil et al., 2011b; 
Mohd Zohdi et al., 2011; Moniruzzaman et al., 2013b; Aziz et al., 2014) 
Acacia honey is produced by Apis mellifera, cultured bees, derived from a plant 
widely used in forest plantation known as tropical acacia species (Acacia mangium) 
(Moniruzzaman et al., 2013a; Zainol et al., 2013). Acacia honeys are famous for its 
pleasant and mild taste and have low pollen content, which can reduce the risks of 
allergies. It is also said that Acacia honey showed slower crystallization process  (bees-
products.com). 
Pineapple honey, which is produced by bees species Apis mellifera normally 
collects nectars form pineapple plants hence the name Pineapple honey (Moniruzzaman 
et al., 2013a). Borneo honeys that were normally used in the studies were from Apiary in 
Kudat Sabah (Khalil et al., 2011b; Moniruzzaman et al., 2013a). The nectar in which the 
smaller size bee (Apis cerana) forages came from Acacia mangium trees and flowers. 
While Trigona (Kelulut) honey derived from species of stingless bees (Tribe 
Meliponini) normally from genus Trigona (Oddo et al., 2008; Zainol et al., 2013; Mail, 
2014; Tualanghoney.com, 2015). These bees stored their honey in pots rather than in 
combs as other honeybees (Oddo et al., 2008) inside hollow tree. Physicochemical 
characterization that was done for Trigona carbonara honey from Australia were shown 
in Table 1.7, and they concluded that several physicochemical properties of Trigona 
honey (moisture content, electrical conductivity and free acidity) are somewhat different 
from honey produced by Apis mellifera bees.  
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 Recently in Malaysia there has been increasing effort in rearing these stingless 
bees inside manmade boxes attached to a tree stump  which normally contained the 
queen bee that was found in the wild or near village area (Mail, 2014).  So far, there are 
still no literature published on Malaysian Trigona honey and its composition maybe 
somewhat different from Australian Trigona honey due to dissimilarities in floral origin 
and geographical region. However according to Malaysian Agricultural Research and 
Development institute (MARDI), Trigona honey possess twice as nutritious as ordinary 
honey (Mail, 2014). It is also believed by the Malays that Trigona (Kelulut) possesses 
anti-ageing and could possibly treat tumour cells when combine with the honey comb 
(Sirisinghe et al., 2007). Recent study on Indonesian methanolic crude extract of Trigona 
honey (three different types)  showed a promising result in cytotoxic effect towards 
human cancer cell lines (Kustiawan et al., 2014) 
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Table 1.6 Honey type and honeybees 
Honey type Floral type Bee species Tree name 
Tualang Multifloral Apis dorsata Tualang tree 
(Koompassia excelsa) 
Gelam Monofloral Apis dorsata, Apis 
mellifera 
Gelam tree 
(Melaleuca cajuputi 
powell) 
Acacia Monofloral Apis mellifera Forest Mangrove 
(Acacia mangium) 
Pineapple Monofloral Apis mellifera Pineapple plant 
(Ananas cornosus) 
Borneo Monofloral Apis cerana Forest Mangrove 
(Acacia mangium) 
Kelulut (Trigona) Multifloral Trigona spp. 
 
Multiforal foraging 
activities of bees, 
Manmade 
boxes/treestump 
 
Summarized from  different studies all over Malaysia  (Aljadi and Yusoff, 2003; Aljadi 
and Kamaruddin, 2004; Hussein et al., 2011; Khalil et al., 2011b; Mohd Zohdi et al., 
2011; Moniruzzaman et al., 2013a; Zainol et al., 2013; Mail, 2014; Samat et al., 2014; 
Tualanghoney.com, 2015). 
 
 
Table 1.7 Characterization of Australian Trigona carbonara honey 
 
Physicochemical properties Mean ±SD 
Colour (Pfund units) 84.6 10.3 
Moisture (g/100 g of honey) 26.5  ± 0.8 
Electrical conductivity (mS/cm) 1.64  ±0.12 
Ash (g/100 g of honey) 0.48  ± 0.06 
HMF (mg/kg of honey 1.2  ±0.6 
pH 4.0  ± 0.1 
Total acidity (mEq/kg of honey) 128.9  ± 23.3 
Diastase (Diastase number) 0.4  ±0.5 
Invertase number 5.7  ±1.5 
Sugars (g/100 g of honey)  
Fructose 24.5  ± 1.9 
Glucose 17.5  ± 2.8 
Maltose 20.3  ±2.9 
Sucrose 1.8  ±0.4 
Fructose + Glucose 42.0  ± 4.5 
Total sugars 64.1  ±1.9 
Water activity (Aw) 0.74  ±0.01 
Flavonoids (mg EQ/100g of honey) 10.02  ± 1.59 
Polyphenols (mg EGA/100g of honey) 55.74 ± 6.11 
 
Adapted from (Oddo et al., 2008) 
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Even though the honey is produced by different bees‟ species and originating 
from different floral source, its basic composition and also its properties is almost 
similar. However, its biochemical and pharmacological activities vary depending on its 
origin and processing.  
Based on the studies done by honey research  team of Universiti Sains Malaysia 
(USM) (Khalil et al., 2011b; Moniruzzaman et al., 2013a; Moniruzzaman et al., 2013b) 
on several local Malaysian honeys (Acacia, Pineapple, Borneo, and Tualang, Gelam, 
Longan, Rubbertree, and Sourwood) revealed that their physicochemical properties such 
as pH, moisture content, electrical conductivity, colour intensity as well as HMF content 
were within the acceptable range approved by international guideline (Codex 
Alimentarious). Malaysian honeys were found to be more acidic when compared to 
Manuka honey. Additionally, Malaysia is currently in the process of developing 
Malaysian honey standards (personal communication). 
All local honeys studied by USM honey research team exhibits antioxidant 
activities with TH have the highest antioxidant properties. Acacia honey is the most 
acidic with highest total sugar and reducing sugar. Pineapple honey had the highest 
concentration of proline and with the lowest moisture content, which means it has the 
highest resistant towards microbial growth and fermentation (Moniruzzaman et al., 
2013a). Studies revealed that the antioxidant capacities and antimicrobial activities of 
local honey is comparable or more superior to Manuka honey (Tan et al., 2009; Ahmed 
and Othman, 2013; Moniruzzaman et al., 2013b). 
Studies done by teams of researchers from Universiti Kebangsaan Malaysia 
(UKM) and Universiti Malaya (UM), showed that Gelam honey exhibit high antioxidant 
properties mainly due to its flavonoids and phenolic content (Hussein et al., 2011). Due 
